Evidence map›Paper›PMID 18485367›Full record

ArticleJournal of psychiatric research2009

Age-related gene expression in Tourette syndrome.

Lisa Lit, Amanda Enstrom, Frank R Sharp, Donald L Gilbert

Open access · greenAbstract read
In one paragraph

Article in Journal of psychiatric research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Molecular Landscape of Tourette's Disorder.International journal of molecular sciences · 2023
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Genetic susceptibility and neurotransmitters in Tourette syndrome.International review of neurobiology · 2013
    Review
  10. Review
  11. Article
  12. Exon expression and alternatively spliced genes in Tourette Syndrome.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2011
    Article
  13. Tourette syndrome: gene expression as a tool to discover drug targets.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2010
    Review
  14. Article
  15. Immunopathogenic mechanisms in tourette syndrome: A critical review.Movement disorders : official journal of the Movement Disorder Society · 2009
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Lisa LitM.I.N.D. Institute, Department of Neurology, University of California at Davis, 2805, 50th Street, Room 2420, Sacramento, CA 95817, United States. Llit@ucdavis.edu
Amanda Enstrom
Frank R Sharp
Donald L Gilbert
University of California, Davis · USCincinnati Children's Hospital Medical Center · USUniversity of California Davis Medical Center · US

Funding

EFFECTIVENESS OF MULTI-DRUG TREATMENTS IN TOURETTE'SK23NS041920 · NINDS · CHILDREN'S HOSPITAL MED CTR (CINCINNATI) · PI GILBERT, DONALD L · 2001 to 2005
$625k
NINDS NIH HHS K23 NS041920NINDS NIH HHS K23 NS41920
6 · The paper itself

Abstract

Because infection and immune responses have been implicated in the pathogenesis of Tourette syndrome (TS), we hypothesized that children with TS would have altered gene expression in blood compared to controls. In addition, because TS symptoms in childhood vary with age, we tested whether gene expression changes that occur with age in TS differ from normal control children. Whole blood was obtained from 30 children and adolescents with TS and 28 healthy children and adolescents matched for age, race, and gender. Gene expression (RNA) was assessed using whole genome Affymetrix microarrays. Age was analyzed as a continuous covariate and also stratified into three groups: 5-9 (common age for tic onset), 10-12 (when tics often peak), and 13-16 (tics may begin to wane). No global differences were found between TS and controls. However, expression of many genes and multiple pathways differed between TS and controls within each age group (5-9, 10-12, and 13-16), including genes involved in the immune-synapse, and proteasome- and ubiquitin-mediated proteolysis pathways. Notably, across age strata, expression of interferon response, viral processing, natural killer and cytotoxic T-lymphocyte cell genes differed. Our findings suggest age-related interferon, immune and protein degradation gene expression differences between TS and controls.

Indexed as

Gene Expression ProfilingAdolescentAge FactorsChildChild, PreschoolFemaleHumansInterferonsMaleMembrane ProteinsOligonucleotide Array Sequence AnalysisTourette SyndromeInterferonsMembrane ProteinsNKG7 protein, human

Identifiers

PMID18485367
PMCPMC2662336
OpenAlexW2061516597

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.